OpenEvidence
verified 2d agoOpenEvidence answers clinical questions with inline citations to peer-reviewed sources, under content agreements with NEJM Group, the JAMA Network, NCCN, Cochrane and Wiley. Free to NPI-verified US clinicians - 757,000+ have signed up, and the company reports 20M+ consultations a month. Funded by advertising, largely pharmaceutical.
Best for: Point-of-care questions where you need the source, not a summary.
Strengths
- Free for verified US clinicians
- Citations to NEJM, JAMA, NCCN and Cochrane
- Reported daily use by over 40% of US physicians
Watch-outs
- Ad-funded, largely by pharma - weigh that on therapeutic questions
- Requires US NPI verification, so limited outside the US
- Answers questions; it won't manage your workflow
Honest pricing
- Pricing model
- FREE
- Real cost, typical use
- $0 · free
- Cost to get listed here
- Free · promoted from $49
- Launched
- 2022·01
Is OpenEvidence worth it?
OpenEvidence launched in January 2022. It's built for point-of-care questions where you need the source, not a summary. What it does best: free for verified US clinicians.
Costs you nothing if you use it like most people do. There's no paid tier waiting behind it. The catch: ad-funded, largely by pharma - weigh that on therapeutic questions.
We checked this listing 2d ago. Still weighing it up? Put OpenEvidence head to head with something else, or describe your task and let AI Match cut the field to three.
Common questions
- How much does OpenEvidence cost?
- Nothing, for the way most people use it. There's no paid tier waiting behind the free one.
- Does OpenEvidence have a free tier?
- Yes, and there's nothing to upgrade into. OpenEvidence is free to use.
- What is OpenEvidence best for?
- Point-of-care questions where you need the source, not a summary. OpenEvidence answers clinical questions with inline citations to peer-reviewed sources, under content agreements with NEJM Group, the JAMA Network, NCCN, Cochrane and Wiley. Free to NPI-verified US clinicians - 757,000+ have signed up, and the company reports 20M+ consultations a month. Funded by advertising, largely pharmaceutical.
- What are the downsides of OpenEvidence?
- The ones we list: ad-funded, largely by pharma - weigh that on therapeutic questions; requires US NPI verification, so limited outside the US; answers questions; it won't manage your workflow. None of them are dealbreakers by themselves. They're what people tend to run into a week or two after signing up.
- What are the best alternatives to OpenEvidence?
- Closest matches in the catalog: Viz.ai, Abridge, UpToDate. All priced the same way, so you can compare what they really cost rather than what they advertise.
- Is the OpenEvidence listing up to date?
- Last checked on 2026-08-08: price, features and the link out. Leave a listing longer than a week and it loses its verified badge until someone looks again.
Healthcare & Medicine alternatives to OpenEvidence
Detects the stroke and pages the team, in parallel.
Ambient notes written during the visit, linked to the audio.
The clinical reference standard, with AI added on top.